Ultra-high-resolution assessment of lesion extension after cryoballoon ablation for pulmonary vein isolation.
ablation < electrophysiology
atrial fibrillation
cryoballoon ablation
electrograms
scar ablation
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
03
07
2022
accepted:
14
10
2022
entrez:
28
11
2022
pubmed:
29
11
2022
medline:
29
11
2022
Statut:
epublish
Résumé
Unrecognized incomplete pulmonary vein (PV) isolation during the index procedure, can be a major cause of clinical recurrences of atrial fibrillation (AF) after cryoballoon (CB) ablation. We aimed to characterize the extension of the lesions produced by CB ablation and to assess the value of using an ultra-high resolution electroanatomic mapping (UHDM) system to detect incomplete CB lesions. Twenty-nine consecutive patients from the CHARISMA registry undergoing AF ablation at four Italian centers were prospectively evaluated. The Rhythmia™ mapping system and the Orion™ (Boston Scientific) mapping catheter were used to systematically map the left atrium and PVs before and after cryoablation. A total of 116 PVs were targeted and isolated. Quantitative assessment of the lesions revealed a significant reduction of the antral surface area of the PV, resulting in an ablated area of 5.7 ± 0.7 cm The lesion extension achieved by the new CB ablation system involved the PV antrum, with less than 50% of the PW remaining untouched. The new system, with short tip and circular mapping catheter, failed to achieve PV isolation in only 0.9% of all PVs treated. [http://clinicaltrials.gov/], identifier [NCT03793998].
Identifiants
pubmed: 36439999
doi: 10.3389/fcvm.2022.985182
pmc: PMC9681817
doi:
Banques de données
ClinicalTrials.gov
['NCT03793998']
Types de publication
Journal Article
Langues
eng
Pagination
985182Informations de copyright
Copyright © 2022 Spera, Narducci, Bencardino, Perna, Bisignani, Pinnacchio, Tondo, Maggio, Stabile, Iacopino, Tundo, Ferraro, De Simone, Malacrida, Pintus, Crea and Pelargonio.
Déclaration de conflit d'intérêts
Authors MM and FPi were salaried Boston Scientific employees. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Heart Rhythm. 2015 Feb;12(2):283-90
pubmed: 25460865
N Engl J Med. 2021 Jan 28;384(4):316-324
pubmed: 33197158
Europace. 2019 Feb 01;21(2):250-258
pubmed: 30321320
J Cardiovasc Electrophysiol. 2021 Apr;32(4):931-932
pubmed: 33590586
J Arrhythm. 2017 Jun;33(3):192-200
pubmed: 28607614
Heart Rhythm. 2017 Oct;14(10):e275-e444
pubmed: 28506916
Europace. 2021 Nov 8;23(11):1757-1766
pubmed: 34151947
J Interv Card Electrophysiol. 2022 Aug;64(2):409-416
pubmed: 34319493
Pacing Clin Electrophysiol. 2022 May;45(5):605-611
pubmed: 35352363
J Interv Card Electrophysiol. 2022 Apr 12;:
pubmed: 35412168
Heart Rhythm. 2017 Sep;14(9):1319-1325
pubmed: 28625929
Circ Arrhythm Electrophysiol. 2020 Aug;13(8):e008667
pubmed: 32628515
Europace. 2020 Nov 1;22(11):1653-1658
pubmed: 32830231
Int J Cardiol. 2018 Nov 1;270:136-142
pubmed: 29929934
Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):667-75
pubmed: 22752925
J Cardiovasc Electrophysiol. 2021 Mar;32(3):580-587
pubmed: 33492749
Europace. 2017 Jan;19(1):48-57
pubmed: 27267554
Circ Arrhythm Electrophysiol. 2014 Feb;7(1):39-45
pubmed: 24385448
J Cardiovasc Electrophysiol. 2022 Jul;33(7):1414-1424
pubmed: 35524404
J Interv Card Electrophysiol. 2022 Oct;65(1):123-131
pubmed: 35488961
Europace. 2021 Aug 6;23(8):1237-1243
pubmed: 33729470